← Back to Search

A4i Intervention for Schizophrenia

N/A
Waitlist Available
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 months.
Awards & highlights

Study Summary

This trial will test the feasibility of a new digital health technology called App4Independence to help address some of the challenges in treating schizophrenia.

Eligible Conditions
  • Schizophrenia
  • Psychosis
  • Schizoaffective Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Treatment-Emergent Adverse Events
Objective App Use
Recruitment
+1 more
Secondary outcome measures
App Strengths and Limitations
Appointment Attendence
Clinical Alliance
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: A4i InterventionExperimental Treatment1 Intervention
App4Independence (A4i) Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data. Specific A4i functionality includes: Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources. Fostering illness self-management through evidence-informed content. A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated). Daily wellness and goal attainment check-ins. An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds. Passively collected data on phone use as a proxy for sleep. A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU).
Group II: Treatment As UsualActive Control1 Intervention
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A4i Intervention
2021
N/A
~90

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
358 Previous Clinical Trials
82,257 Total Patients Enrolled
58 Trials studying Schizophrenia
4,141 Patients Enrolled for Schizophrenia
~21 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top